- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04226235
Acute Effects of Vinyasa Yoga on Vascular Function
January 8, 2020 updated by: Texas State University
Acute Effects of Yoga on Arterial Stiffness, Wave Reflection, and Blood Markers in Normotensive and Hypertensive Adults
The purpose of this investigation was to determine the acute effects of vinyasa yoga on arterial stiffness, wave reflection, and blood markers in normo- and hyper-tensive adults.
To address this aim, fifteen normotensive adults and 15 adults with elevated blood pressure or stage 1 hypertension with a minimum of 3 months of yoga practice experience were enrolled.
Carotid-femoral pulse wave velocity (cf-PWV), augmentation index (AIx), lipid profile, and glucose concentrations were assessed at baseline and immediately following a 1-hour vinyasa yoga session.
Study Overview
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
San Marcos, Texas, United States, 78666
- Texas State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Having normal (systolic blood pressure <120 mm Hg with a diastolic <80 mm Hg) or elevated blood pressure (systolic blood pressure 120-129 mm Hg) or stage 1 hypertension (systolic blood pressure 130-139 mm Hg or a diastolic blood pressure 80-89 mm Hg).
- Must have had at least 3 months of prior yoga experience.
Exclusion Criteria:
- A history of cardiovascular disease or cardiac events, pregnancy, infection within the last 4 weeks, chronic obstructive pulmonary disease (COPD), endocrine or renal disease, metabolic disorders, or debilitating muscular, joint and bone injury.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: 1-hour vinyasa yoga session
One hour of vinyasa yoga was completed by all participants while following a DVD.
|
a 1-hour yoga session was completed by all participants following a DVD.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Arterial stiffness
Time Frame: Once before the yoga session
|
Carotid-femoral pulse wave velocity
|
Once before the yoga session
|
|
Arterial stiffness
Time Frame: Once immediately after the 1-hour yoga session
|
Carotid-femoral pulse wave velocity
|
Once immediately after the 1-hour yoga session
|
|
Wave reflection
Time Frame: Once before the yoga session
|
Augmentation index
|
Once before the yoga session
|
|
Wave reflection
Time Frame: Once immediately after the 1-hour yoga session
|
Augmentation index
|
Once immediately after the 1-hour yoga session
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lipid profile
Time Frame: Once before the yoga session
|
Blood samples obtained via finger stick and analyzed for total-, LDL-, and HDL-cholesterol and triglyceride concentrations using reflectance photometry.
|
Once before the yoga session
|
|
Lipid profile
Time Frame: Once immediately after the 1-hour yoga session
|
Blood samples obtained via finger stick and analyzed for total-, LDL-, and HDL-cholesterol and triglyceride concentrations using reflectance photometry.
|
Once immediately after the 1-hour yoga session
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 14, 2018
Primary Completion (ACTUAL)
June 1, 2019
Study Completion (ACTUAL)
June 1, 2019
Study Registration Dates
First Submitted
January 7, 2020
First Submitted That Met QC Criteria
January 8, 2020
First Posted (ACTUAL)
January 13, 2020
Study Record Updates
Last Update Posted (ACTUAL)
January 13, 2020
Last Update Submitted That Met QC Criteria
January 8, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 530
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.